Medroxyprogesterone acetate and homozygous sickle-cell disease.
about
Pharmacological interventions for painful sickle cell vaso-occlusive crises in adultsDrugs for preventing red blood cell dehydration in people with sickle cell diseaseFluid replacement therapy for acute episodes of pain in people with sickle cell diseasePain management for sickle cell disease in children and adultsDrugs for preventing red blood cell dehydration in people with sickle cell diseaseFluid replacement therapy for acute episodes of pain in people with sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseaseFluid replacement therapy for acute episodes of pain in people with sickle cell diseaseSteroid hormones for contraception in women with sickle cell diseasePain management for sickle cell disease in children and adultsThe progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.Management of sickle cell disease. Non-addictive analgesics can be as effective as morphine and pethidine.The emerging understanding of sickle cell disease.Depo-Provera--ethical issues in its testing and distribution."I have a bone stuck in my throat".Sickle haemoglobin and pregnancy.Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.Glomerular function and hyperuricaemia in sickle cell diseaseContraception in women with medical problems.Common gynecological challenges in adolescents with sickle cell disease.Fluid replacement therapy for acute episodes of pain in people with sickle cell disease.Sickle cell disease and contraception.Fetal haemoglobin and pregnancy in homozygous sickle cell disease.Fertility challenges for women with sickle cell disease.Trends in family planning and counselling for women with sickle cell disease in the UK over two decades.Contraceptive practices in women with sickle-cell disease.Norplant use by women with sickle cell disease.
P2860
Q24185822-52459BFE-20AD-4B76-A404-2CD66F90F193Q24186046-861256E5-C0E4-457E-B6E5-24548E0F0AC0Q24187305-FE6BB63B-E5C0-4383-9BC5-69FFF813408AQ24197555-5F3C2599-FE89-404D-A0CD-5F220763F205Q24202032-4E6EB323-9EBC-4F9C-9B06-96CCBDE6E308Q24202799-9C404E47-B1AF-447B-9AC5-80DD75C17B61Q24240777-53CFE8A3-15CE-4209-AF74-CD1573BA1811Q24245022-95D0BEDF-14E3-4BA0-8CAB-F46AB23ACDFCQ24245507-D6A2E404-976F-41E9-98C5-6261677D52A3Q24246031-83297F04-7F2F-4BCA-B130-708D16126D5AQ25257485-124D0B1D-C7BB-4455-AD3E-8064DB57D947Q33789475-8139FA32-EF5A-4BCC-95C8-825192FE9CDEQ33932507-AFF10E7C-BC4F-41A6-9177-83228192FD9AQ34379406-234DC2B3-5B70-410F-AC10-00E7557606CBQ34551474-4CBCA647-E233-4949-B283-6EBF4CA05A36Q34994319-D4F5D5F0-1D7B-427E-A858-974CC836CAB4Q35098104-79DD47EF-8615-4B22-9B1D-31940DE86D80Q37185093-C765B5A9-6DDC-4BA0-95A2-1E547DC78660Q37186251-5E2972B2-4EF0-47D0-BD4D-8CF68C47A8B0Q38650270-C43BFB87-51E2-44B4-B989-9819D0391BFDQ38651918-C05FF614-F8A7-48D6-BCD8-A7B82001F4B1Q43151810-F9CFCD84-F811-49D7-9374-90E2F88FF8D1Q45177119-A9B937AD-8B96-4DA4-A3BB-8FE72EF21F45Q45871717-291FFA2C-53C4-443B-A8D1-41C233CEA5E4Q46316389-054556C8-0056-439E-9E32-658F2260056DQ47613822-8411E071-D985-403D-AACC-68E2FAA15B36Q50672457-415EFB49-C3B2-43FA-AAF7-ADB8C0F103A8
P2860
Medroxyprogesterone acetate and homozygous sickle-cell disease.
description
1982 nî lūn-bûn
@nan
1982 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@ast
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@en
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@nl
type
label
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@ast
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@en
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@nl
prefLabel
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@ast
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@en
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@nl
P2093
P1433
P1476
Medroxyprogesterone acetate and homozygous sickle-cell disease.
@en
P2093
G R Serjeant
K De Ceulaer
P304
P356
10.1016/S0140-6736(82)90320-8
P407
P577
1982-07-01T00:00:00Z